Arthur C. Louie
Technik-/Wissenschafts-/F&E-Leiter bei CELATOR PHARMACEUTICALS INC
Profil
Arthur C.
Louie currently works at Celator Pharmaceuticals, Inc., as Chief Medical Officer.
Dr. Louie also formerly worked at Bristol Myers Squibb Co., as Director-Cancer Research, Human Genome Sciences, Inc., as Vice President-Medical Affairs, XOMA Corp., as Vice President-Clinical Research, Proneuron Biotechnologies, Inc., as Principal, Wellstat Biologics Corp., as Principal, and Chiron Therapeutics, Inc., as Principal.
Dr. Louie received his undergraduate degree from Haverford College and doctorate degree from New York University School of Medicine.
Aktive Positionen von Arthur C. Louie
| Unternehmen | Position | Beginn |
|---|---|---|
| CELATOR PHARMACEUTICALS INC | Technik-/Wissenschafts-/F&E-Leiter | - |
Ehemalige bekannte Positionen von Arthur C. Louie
| Unternehmen | Position | Ende |
|---|---|---|
| Chiron Therapeutics, Inc. | Corporate Officer/Principal | - |
Wellstat Biologics Corp.
 Wellstat Biologics Corp. Pharmaceuticals: MajorHealth Technology Wellstat Biologics Corp. is a private company that focuses on the development and commercialization of biological agents. The company is based in Gaithersburg, MD. | Corporate Officer/Principal | - |
| XOMA CORPORATION | Technik-/Wissenschafts-/F&E-Leiter | - |
Proneuron Biotechnologies, Inc.
 Proneuron Biotechnologies, Inc. Pharmaceuticals: MajorHealth Technology Proneuron Biotechnologies, Inc. develops therapies for nervous disorders. The company develops therapies for neurological, ophthalmologic and immune-related disorders such as spinal cord injuries, multiple sclerosis, glaucoma, Parkinson's disease and Alzheimer's diseases. It was founded in 1996 and is headquartered in New York, NY. | Corporate Officer/Principal | - |
| BRISTOL-MYERS SQUIBB COMPANY | Corporate Officer/Principal | - |
Ausbildung von Arthur C. Louie
| Haverford College | Undergraduate Degree |
| New York University School of Medicine | Doctorate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
| Börsennotierte Unternehmen | 2 |
|---|---|
| BRISTOL-MYERS SQUIBB COMPANY | Health Technology |
| XOMA CORPORATION | Health Technology |
| Private Unternehmen | 5 |
|---|---|
Human Genome Sciences, Inc.
 Human Genome Sciences, Inc. Medical SpecialtiesHealth Technology Human Genome Sciences, Inc. is a biopharmaceutical company that exists to place new therapies into the hands of those battling serious disease. Its lead products include BENLYSTA for systemic lupus erythematosus and raxibacumab for inhalation anthrax. The firm's other products include, mapatumumab, darapladib, albiglutide, ZALBIN, HGS1036 and HGS1029. The company was founded by Alan G. Walton and William A. Haseltine in 1992 and is headquartered in Gaithersburg, MD. | Health Technology |
Celator Pharmaceuticals, Inc.
 Celator Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Celator Pharmaceuticals, Inc. engages in the research and development of biopharmaceutical products. The company was founded by Lawrence David Mayer, and Marcel B. Bally in 1999 and is headquartered in Ewing, NJ. | Health Technology |
Proneuron Biotechnologies, Inc.
Proneuron Biotechnologies, Inc. Pharmaceuticals: MajorHealth Technology Proneuron Biotechnologies, Inc. develops therapies for nervous disorders. The company develops therapies for neurological, ophthalmologic and immune-related disorders such as spinal cord injuries, multiple sclerosis, glaucoma, Parkinson's disease and Alzheimer's diseases. It was founded in 1996 and is headquartered in New York, NY. | Health Technology |
Wellstat Biologics Corp.
Wellstat Biologics Corp. Pharmaceuticals: MajorHealth Technology Wellstat Biologics Corp. is a private company that focuses on the development and commercialization of biological agents. The company is based in Gaithersburg, MD. | Health Technology |
| Chiron Therapeutics, Inc. |
